secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oruka Therapeutics, Inc. (ORKA)
CIK:        0000907654
Form:       8-K
Filed at:   2024-08-16T23:59:59+00:00
Accession:  0001213900-24-070263
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ARCA biopharma declares special dividend of $1.59/share in connection with proposed Oruka merger
--------------------------------------------------------------------------------

- Special dividend estimated at $1.59 per share, payable to stockholders of record as of August 26, 2024.
- Dividend payment date scheduled for August 28, 2024, subject to stockholder approval of the Oruka merger.
- Merger vote at special meeting on August 22, 2024; merger close expected August 29, 2024.
- Dividend amount based on ARCA's net cash exceeding $5M; actual amount may vary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/907654/000121390024070263/0001213900-24-070263-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/907654/000121390024070263/ea0211617-8k425_arcabio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-070263

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer